CliffBio
small molecule

CARTROL

CARTEOLOL HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyAbbVie Inc. →See this company's full patent-cliff portfolio

Drug detail

Brand nameCARTROL
Active ingredientCARTEOLOL HYDROCHLORIDE
Strength2.5MG
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalDecember 1988
Marketing statusDISCN

More from AbbVie Inc.

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

CARTROL patent cliff — loss of exclusivity — | CliffBio